148 related articles for article (PubMed ID: 11555709)
1. New approaches to blood and marrow transplantation for patients with low-grade lymphomas.
Berdeja JG; Flinn IW
Curr Opin Oncol; 2001 Sep; 13(5):335-41. PubMed ID: 11555709
[TBL] [Abstract][Full Text] [Related]
2. The role of the anti-CD20 antibody rituximab in hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
Naparstek E
Curr Hematol Rep; 2005 Jul; 4(4):276-83. PubMed ID: 16009042
[TBL] [Abstract][Full Text] [Related]
3. Incorporating monoclonal antibodies in blood and marrow transplantation.
Malek SN; Flinn IW
Semin Oncol; 2003 Aug; 30(4):520-30. PubMed ID: 12939721
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
[TBL] [Abstract][Full Text] [Related]
5. Enrich/purge technique for peripheral stem cells more effective, less costly than bone marrow for transplant.
Oncology (Williston Park); 1995 Dec; 9(12):1341-2. PubMed ID: 8771107
[No Abstract] [Full Text] [Related]
6. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.
Alvarnas JC; Forman SJ
Oncology (Williston Park); 2004 Jun; 18(7):867-76; discussion 876-8, 881, 884. PubMed ID: 15255171
[TBL] [Abstract][Full Text] [Related]
7. Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma.
Ogniben E; Hohaus S; Kvalheim G; Dörken B; Haas R
Prog Clin Biol Res; 1992; 377():189-95. PubMed ID: 1438415
[No Abstract] [Full Text] [Related]
8. Bone marrow transplantation for non-Hodgkin's lymphoma: a review.
Salzman DE; Briggs AD; Vaughan WP
Am J Med Sci; 1997 Apr; 313(4):228-35. PubMed ID: 9099153
[TBL] [Abstract][Full Text] [Related]
9. Blood and marrow transplantation in relapsed or refractory non-Hodgkin's lymphoma.
Stiff PJ
Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):56-62. PubMed ID: 9830634
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Aksentijevich I; Flinn IW
Cancer Control; 2002; 9(2):99-105. PubMed ID: 12008655
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
12. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry.
Williams CD; Goldstone AH; Pearce RM; Philip T; Hartmann O; Colombat P; Santini G; Foulard L; Gorin NC
J Clin Oncol; 1996 Sep; 14(9):2454-64. PubMed ID: 8823323
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for low-grade B-cell malignancies.
Gribben JG
Curr Opin Oncol; 1997 Mar; 9(2):117-21. PubMed ID: 9161787
[TBL] [Abstract][Full Text] [Related]
14. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
Alonso K; Medenica R; Morehead G
Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
[No Abstract] [Full Text] [Related]
15. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
[TBL] [Abstract][Full Text] [Related]
16. Blood and marrow transplant for lymphoma patients with HIV/AIDS.
Wagner-Johnston ND; Ambinder RF
Curr Opin Oncol; 2008 Mar; 20(2):201-5. PubMed ID: 18300771
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem-cell transplantation for non-Hodgkin's lymphomas: the role of graft purging and radiotherapy posttransplantation--results of a retrospective analysis on 120 patients autografted in a single institution.
Fouillard L; Laporte JP; Labopin M; Lesage S; Isnard F; Douay L; Lopez M; Aoudjhane M; Zunic P; Cheron N; Stachowiak J; Lemonnier MP; Andreu G; Belkacemi Y; Noël-Walter MP; Morel P; Fenaux P; Jouet JP; Bauters F; Najman A; Gorin NC
J Clin Oncol; 1998 Aug; 16(8):2803-16. PubMed ID: 9704733
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in low-grade non-Hodgkin's lymphoma.
Lazarus HM
Leuk Lymphoma; 1995 Apr; 17(3-4):199-210. PubMed ID: 8580788
[TBL] [Abstract][Full Text] [Related]
19. Purging the bone marrow in non-Hodgkin's lymphomas. Is there any evidence of its value?
Rizzoli V; Carlo-Stella C; Almici C; Caramatti C; Mangoni L
Leuk Lymphoma; 1992; 7 Suppl():7-10. PubMed ID: 1493461
[No Abstract] [Full Text] [Related]
20. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
